Rhythm Pharmaceuticals, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$975Kgeneral payments (2019-2025)
$15Kresearch payments (2019-2025)
3,288clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Jennifer Paisley | Lawrenceburg, IN | Internal Medicine | $54,123.54 |
| Gitanjali Srivastava | Nashville, TN | Obesity Medicine (Internal Medicine) | $42,117.65 |
| Juliana Simonetti | Boston, MA | Internal Medicine | $36,091.63 |
| Vidhu Thaker | New York, NY | Pediatric Endocrinology | $32,556.51 |
| Christy Davis | Jackson, MS | Family | $29,163.94 |
| Joshua Zaritsky | Phoenix, AZ | Pediatric Nephrology | $27,089.39 |
| Ashley Shoemaker | Nashville, TN | Pediatric Endocrinology | $25,853.80 |
| Uzoma Okorie | Marshfield, WI | Pediatric Cardiology | $25,726.86 |
| Svetlana Ten | Staten Island, NY | Pediatric Endocrinology | $25,390.65 |
| Katie Queen | Bogalusa, LA | Pediatrics | $25,019.99 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.